Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that the U.S. Food & Drug ...

FIM MotoGP race stewards: what they do, how they make decisions and enforce penalties to ensure fair, safe racing across ...

Rendering: The project will add affordable housing, office and bioscience space. (Photo courtesy of Century Housing Corp.) A major mixed-use wellness and education campus next to Charles R. Drew ...

Discover how thinXXS helped Pattern Bioscience accelerate digital droplet chip development through precision manufacturing, ...

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its CEO, Rob Fried, will ...

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ science, today announced the formal launch of the first drug candidate of NAD Pharmaceuticals Corp., its wholly owned subsidiary ...

The ROTOR platform will initially be developed and validated using rotavirus vaccine datasets.

SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered platform for evidence-based clinical development decision-making. The project will support next-generation injectable ...

Cell-cell interaction data captures how cells influence one another and how those interactions shape biological function. While single-cell sequencing and spatial biology have tra ...

Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world solutions, today announced ...

For Lower Queen Anne, the swap sets up a familiar Seattle balancing act. Neighbors and city planners will be weighing several ...

The developer is broadening its focus beyond life sciences as the region's lab market weathers rising vacancy rates and decreased funding.